Literature DB >> 5527023

Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.

H E Skipper, F M Schabel, L B Mellett, J A Montgomery, L J Wilkoff, H H Lloyd, R W Brockman.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5527023

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  70 in total

Review 1.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Biological features and chemosensitivity of human colorectal cancer xenografted in nude mice.

Authors:  K Yamada
Journal:  Gastroenterol Jpn       Date:  1987-10

Review 3.  Current directions in chemotherapy for colorectal cancer.

Authors:  Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

4.  FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.

Authors:  Filippo Pietrantonio; Claudia Maggi; Giuseppe Fanetti; Roberto Iacovelli; Maria Di Bartolomeo; Francesca Ricchini; Marcello Deraco; Federica Perrone; Dario Baratti; Shigeki Kusamura; Elena Tamborini; Alessandra Castano; Paola Valentina Consonni; Ilaria Bossi; Cecilia Gavazzi; Massimo Milione; Giuseppe Pelosi; Filippo de Braud
Journal:  Oncologist       Date:  2014-06-20

5.  Center of cancer systems biology second annual workshop--tumor metronomics: timing and dose level dynamics.

Authors:  Philip Hahnfeldt; Lynn Hlatky; Giannoula Lakka Klement
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

6.  Clinical pharmacokinetics of oral CCNU (lomustine).

Authors:  F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.

Authors:  R Ludwig; D S Alberts; T P Miller; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Chemical and biological stability of anticancer drugs used in a human tumor clonogenic assay.

Authors:  R Ludwig; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Multicompartment models of cancer chemotherapy incorporating resistant cell populations.

Authors:  H N Duc; P M Nickolls
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

10.  Clinical effects of anticancer drugs to pancreatic diseases as protein synthesis inhibitors.

Authors:  Y Kinami; I Miyazaki; M Kawamura; M Sugii; Y Sakane
Journal:  Gastroenterol Jpn       Date:  1976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.